Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home
  
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Genetic Tug of War Before Cells Decide Fate
Researchers report that as developing blood cells are triggered by genetic signals firing on and off, a 'tug of war' occurs.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Linkage Biosciences Awarded NHS Contract
Comapny announces that it has been awarded a four-year contract by NHS Blood and Transplant (NHSBT) in the UK for implementation of the LinkSeq™ Real-Time PCR HLA typing product.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Frankfurter Fraud: Finding Out What’s In Your Hot Dog
Scientists have developed a technique to test the meat content of Frankfurters.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Keeping Cells in Shape to Fight Sepsis
Boosting levels of a protein that controls the shape and activity of a crucial group of white blood cells improves survival and recovery chances during sepsis.
This 3D Printer Can Detect Infectious Diseases
Researchers at AI Biosciences, Inc. have repurposed 3D printers into machines capable of performing sample preparation and DNA amplification.

Epigenetics Market Trends 2011
Bookmark and Share

Published: January 2011
Pages: 76

This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers.

This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.

This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and therefore provides an excellent proxy for the understanding of the research trends operative in this space.

In addition to characterization of the epigenetics research marketplace, this report also presents an analysis of epigenetic biomarkers and their deployment as potential diagnostics. Also presented herein are the efforts vis-à-vis deployment of epigenetics as therapeutics—in this vein the clinical pipeline as it exists currently is presented.

This data-driven characterization of the epigenetics research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Characterization of Epigenetics Modifications
  • DNA Methylation, the Various Histone Modifications and their Qualitative Effects In Vivo
  • Epigenetic Silencing of Genes and Pathways: Mechanism and Effects
  • Tumor Suppressor Genes Silenced In Vivo
  • Specific Genes Modulated via Epigenetics In Various Diseases
  • Market Segmentation of Epigenetics by Disease Class
  • Epigenetics Market Segmentation
  • Epigenetics Market Segmentation by End-User Research Penetrance
  • Epigenetics Market Quantitative Segmentation by type of Modification Studied
  • Epigenetics Market Segmentation by Type of HDAC Studied
  • Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis
  • Emerging Trends and Themes in Epigenetics
  • Current Studies of microRNAs, non-coding RNAs, and Tumor Suppressor Genes in the Epigenetics Marketplace
  • Epigenetics-based Diagnostics: Epigenetics-based Biomarkers and their Current Status
  • Epigenetics-based Therapeutics: The current Clinical Pipeline of Approved and In-Development Therapeutics


Related Content

Agendas online
The conference agendas for Advances in qPCR, RNAi & miRNA World Congress, Epigenetics World Congress and Next-Gen Sequencing Congress to be held 26-27 April, 2011 in Boston, MA, USA have now been released.
Friday, January 07, 2011
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!